KENNETH S KOSIK, M.D.
Neurology in Santa Barbara, CA
License number
California 45692
Category
Neurology
Type
Neurology
Address
Address
Neuro Res Institute Ucsb, Santa Barbara, CA 93106
Phone
(805) 893-5222
Organization information
See more information about KENNETH S KOSIK at bizstanding.comKenneth S Kosik
968 N Patterson Ave, Santa Barbara, CA 93111
Phone:
(805) 893-5222 (Phone)
Professional information
Professor At University Of California
Position:
executive director at Cognitive Fitness and Innovative Therapies (CFIT), Harriman Professor of Neuroscience at University of California Santa Barbara
Location:
Santa Barbara, California Area
Industry:
Research
Work:
Cognitive Fitness and Innovative Therapies (CFIT)
since 2008
-
executive director
University of California Santa Barbara
since Jul 2004
-
Harriman Professor of Neuroscience
Harvard University
1980 - 2004
-
Professor
Dr. Kenneth S Kosik, Santa Barbara CA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
Bio Ii STE 6139, Santa Barbara 93106
Ucsb, Santa Barbara 93106
(805) 893-5222 (Phone)
Ucsb, Santa Barbara 93106
(805) 893-5222 (Phone)
Certifications:
Neurology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Medical College of Pennsylvania
Graduated: 1976
Faulkner Hospital
Tuft-New Eng Med Ctr
Harvard Medical School
Medical College of Pennsylvania
Graduated: 1976
Faulkner Hospital
Tuft-New Eng Med Ctr
Harvard Medical School
Sirna Based Methods For Treating Alzheimer's Disease
US Patent:
2007018, Aug 9, 2007
Filed:
Aug 9, 2004
Appl. No.:
10/567537
Inventors:
Kenneth Kosik - Santa Barbara CA, US
International Classification:
A61K 48/00, C07H 21/02, C12N 5/08
US Classification:
514044000, 536023100, 435455000, 435368000
Abstract:
The present invention relates to siRNA molecules derived from BACE1 and BACE2 genes. Accordingly, provided herein are siRNA molecules comprising a nucleotide sequence consisting essentially of a BACE1 or BACE2 gene. Also provided are methods for reducing the level of BACE1 protein in a cell. Further provided are methods for preparing a pharmaceutical composition comprising an siRNA with a pharmaceutically acceptable carrier.